Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11880408 | 0.98 | NPC1 (0.57) | NPC1RAB9AEPHX2TAAR1ALDH1A1 | |
| SCHEMBL20348676 | 0.92 | NPC1 (0.52) | NPC1RAB9AEPHX2TAAR1ALDH1A1 | |
| SCHEMBL10204064 | 0.91 | CES2 (0.50) | NPC1RAB9AEPHX2ALDH1A1CES2 | |
| SCHEMBL8059347 | 0.81 | NPC1 (0.54) | NPC1RAB9AEPHX2ALDH1A1KDM4E | |
| SCHEMBL9355178 | 0.81 | NPC1 (0.55) | NPC1RAB9AEPHX2TAAR1ALDH1A1 | |
| SCHEMBL9355594 | 0.81 | NPC1 (0.55) | NPC1RAB9AEPHX2TAAR1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL10527779 | 0.81 | CYP19A1 (0.55) | NPC1RAB9AALDH1A1KDM4EEPHX1 | |
| SCHEMBL10528771 | 0.81 | CYP19A1 (0.55) | ALDH1A1KDM4EEPHX1MEN1KMT2A | |
| SCHEMBL16178630 | 0.80 | NPC1 (0.54) | NPC1RAB9AEPHX2 | |
| SCHEMBL7501904 | 0.79 | DRD2 (0.63) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2362765-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2011-09-07 | — | — | EP | claimed |
| WO-2010065446-A2 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2010-06-10 | — | — | WO | claimed |
| WO-2021125695-A1 | CURABLE COMPOSITION FOR INKJET PRINTING, AND ORGANIC LIGHT-EMITTING DISPLAY DEVICE COMPRISING SAME | 주식회사 두산 | 2021-06-24 | — | — | WO | disclosed |
| EP-1403260-B1 | Optically active epoxy compounds and processes for their production | TOSOH CORP (JP) | 2007-08-08 | — | — | EP | disclosed |
| US-7169944-B2 | Optically active epoxy compounds and processes for their production | TOSOH CORPORATION (JP) | 2007-01-30 | — | — | US | disclosed |
| US-20040063979-A1 | Optically active epoxy compounds and processes for their production | TOSOH CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1403260-A2 | Optically active epoxy compounds and processes for their production | Tosoh Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-4067886-A | REACTING KETONES AND KETALS WITH HALOGEN | LEVER BROTHERS COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063979-A1 | Optically active epoxy compounds and processes for their production | CYP51A1, CYP11B1, PTGES | NPC1 1480/4885RAB9A 931/4885EPHX2 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.